Psychiatry · Mental health
Depression treatment in China
Class A psychiatry departments at major academic centres offer evidence-based depression care — pharmacotherapy, psychotherapy (CBT, IPT), and structured follow-up — with English-speaking clinicians available.
Overview
Major depressive disorder is one of the most common psychiatric conditions globally — and one of the most treatable when addressed promptly. Effective treatments exist; outcomes are best when combination care (medication + therapy) is matched to severity. Class A academic psychiatry departments in China offer this care at substantially lower cost than US/UK/AU private pay.
Common symptoms
- Depressed mood most of the day, nearly every day
- Markedly diminished interest or pleasure (anhedonia)
- Significant weight change or appetite disturbance
- Insomnia or hypersomnia
- Fatigue or loss of energy
- Feelings of worthlessness or excessive guilt
- Diminished concentration
- Thoughts of death or self-harm — clinical attention warranted regardless of total severity
Risk factors
- Family history
- Prior depressive episodes
- Chronic medical illness
- Substance use
- Stressful life events, relationship loss
- Postpartum (separate clinical entity)
Standard diagnostic workup
Cost band at Class A international department: USD 140–280 all-in.
- Structured psychiatric interview
- PHQ-9 severity score
- Differential rule-out: thyroid (TSH), B12, vitamin D, sleep, substance use, medical mimics
- Suicide risk assessment
- Past treatment review and response history
Treatment options
SSRIs (sertraline, escitalopram)
First-line pharmacotherapy. Generic, inexpensive in China at USD 5–25/month.
SNRIs (venlafaxine, duloxetine)
Particularly useful when comorbid pain or anxiety predominate.
Cognitive behavioural therapy (CBT)
Strongest evidence for psychotherapy in depression. Available in English-speaking format at major academic centres.
Interpersonal therapy (IPT)
Equally effective with CBT for many patients, particularly when relationship / role transitions predominate.
Combination medication + therapy
Standard of care for moderate-to-severe depression; outperforms either alone.
Treatment-resistant approaches (esketamine, augmentation)
For patients failing 2+ adequate trials. Available at academic psychiatry departments.
Frequently asked
- How severe is my depression?
- Take our free PHQ-9 self-test for the global standard depression screener. Scores of 10+ warrant clinical evaluation.
- Are mental health treatments confidential in China?
- Yes within standard medical confidentiality protections. Class A psychiatry departments at academic hospitals (Shanghai Mental Health Center, PKU Sixth) treat international patients with the same protections as domestic.
- What if I'm in crisis right now?
- Contact local emergency services immediately. Self-harm or suicidal thoughts always warrant urgent in-person evaluation, not an online screener.
Depression screener (PHQ-9)
The 9-item Patient Health Questionnaire — the most widely used validated depression screener in primary care worldwide. Free, 3 minutes, immediate results.
Take the Depression screenerRelated specialty
Psychiatry · Mental health hub →Talk to a senior physician
Free 30-minute video consult to review your case. We'll quote a workup and treatment plan at a Class A partner hospital — no commitment.
Book free consult